Literature DB >> 12656874

Laminin-5 gamma2-chain and collagenase-2 (MMP-8) in human peri-implant sulcular fluid.

Marjo J Kivelä-Rajamäki1, Olli P Teronen, Päivi Maisi, Ville Husa, Taina I Tervahartiala, Emma M Pirilä, Tuula A Salo, Liisa Mellanen, Timo A Sorsa.   

Abstract

Laminin-5 (LN-5) is an important epithelial cell-derived structural and adhesive component in hemidesmosomes and basement membranes (BM). In peri-implant tissue, gingival BM underlies the junctional epithelium (JE) and reflects the peri-implant health. Matrix metalloproteinase-8 (MMP-8 or collagenase-2) is one of the key mediators of periodontal tissue destruction. Western immunoblotting with image analysis was used to quantitate the molecular forms of LN-5 gamma2-chain and MMP-8 in peri-implant sulcular fluid (PISF) from healthy and diseased implants. These observations were related to the recorded gingival (GI) and bone resorption (BR) indices of the studied sites. Altogether, 72 PISF samples from osseointegrated dental implants were examined. Significantly elevated levels of fragmented LN-5 gamma2-chain species (45 and 70 kDa) and MMP-8 immunoreactivities were observed in diseased PISF in relation to healthy PISF. The elevated levels of both LN-5 gamma2-chain 45 and 70 kDa fragments and MMP-8 in diseased PISF from peri-mucositis (BR = 0) and peri-implantitis (BR >/= 1) lesions strongly correlated with elevated GI. Low levels - almost comparable to those seen in healthy control PISF - were seen in PISF from peri-implantitis lesions (BR >/= 1) with no GI. Activation of 75 kDa neutrophil (PMN)-type proMMP-8 to 10 kDa lower-molecular-size active forms was especially detected in PISF from peri-implantitis with elevated GI. These cross-sectional findings indicate that elevated MMP-8 and LN-5 gamma2-chain fragment levels in PISF can reflect the active phase of the inflammatory peri-implant disease. Longitudinal studies are required to assess their use, either alone or in combination as molecular biochemical PISF markers, to predict the risk of progression of peri-implantitis, as well as to monitor the impact of treatment of the disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12656874     DOI: 10.1034/j.1600-0501.2003.140204.x

Source DB:  PubMed          Journal:  Clin Oral Implants Res        ISSN: 0905-7161            Impact factor:   5.977


  10 in total

1.  Peri-Implant Sulcus Fluid (PISF) Matrix Metalloproteinase (MMP) -8 Levels in Peri-Implantitis.

Authors:  René Thierbach; Kurt Maier; Timo Sorsa; Päivi Mäntylä
Journal:  J Clin Diagn Res       Date:  2016-05-01

Review 2.  Oral fluid-based biomarkers of alveolar bone loss in periodontitis.

Authors:  Janet S Kinney; Christoph A Ramseier; William V Giannobile
Journal:  Ann N Y Acad Sci       Date:  2007-03       Impact factor: 5.691

Review 3.  Oral fluid-based biomarkers in periodontal disease - part 2. Gingival crevicular fluid.

Authors:  Raed AlRowis; Hani S AlMoharib; Abdulrahman AlMubarak; Jagankumar Bhaskardoss; R S Preethanath; Sukumaran Anil
Journal:  J Int Oral Health       Date:  2014-09

4.  Evaluation of Metalloproteinase-8 Levels in Crevicular Fluid of Patients with Healthy Implants or Periodontitis.

Authors:  Paweł Aleksandrowicz; Paulina Żelechowska; Justyna Agier; Katarzyna Starska; Krzysztof Kędzierski; Joanna Wysokińska-Miszczuk; Ewa Brzezińska-Błaszczyk
Journal:  Mediators Inflamm       Date:  2017-07-05       Impact factor: 4.711

Review 5.  Salivary Diagnostics-Point-of-Care diagnostics of MMP-8 in dentistry and medicine.

Authors:  Nilminie Rathnayake; Dirk-Rolf Gieselmann; Anna Maria Heikkinen; Taina Tervahartiala; Timo Sorsa
Journal:  Diagnostics (Basel)       Date:  2017-01-20

Review 6.  Current understanding of genetic polymorphisms as biomarkers for risk of biological complications in implantology.

Authors:  Asier Eguia Del Valle; José López-Vicente; Rafael Martínez-Conde; Luis-Antonio Aguirre-Zorzano
Journal:  J Clin Exp Dent       Date:  2018-10-01

7.  Calprotectin and cross-linked N-telopeptides of type I collagen levels in crevicular fluid from implant sites with peri-implant diseases: a pilot study.

Authors:  Eijiro Sakamoto; Rie Kido; Yoritoki Tomotake; Yoshihito Naitou; Yuichi Ishida; Jun-Ichi Kido
Journal:  Int J Implant Dent       Date:  2018-09-13

Review 8.  Matrix Metalloproteinase-8 as an Inflammatory and Prevention Biomarker in Periodontal and Peri-Implant Diseases.

Authors:  Ahmed Al-Majid; Saeed Alassiri; Nilminie Rathnayake; Taina Tervahartiala; Dirk-Rolf Gieselmann; Timo Sorsa
Journal:  Int J Dent       Date:  2018-09-16

9.  Correlation between Peri-Implant Marginal Bone Loss Progression and Peri-Implant Sulcular Fluid Levels of Metalloproteinase-8.

Authors:  Renzo Guarnieri; Alessio Zanza; Maurilio D'Angelo; Dario Di Nardo; Andrea Del Giudice; Alessandro Mazzoni; Rodolfo Reda; Luca Testarelli
Journal:  J Pers Med       Date:  2022-01-06

10.  Active MMP-8 point-of-care (PoC)/chairside enzyme-test as an adjunctive tool for early and real-time diagnosis of peri-implantitis.

Authors:  Hanna Lähteenmäki; Taina Tervahartiala; Ismo T Räisänen; Pirjo Pärnänen; Matti Mauramo; Shipra Gupta; Victoria Sampson; Nilminie Rathnayake; Anna-Maria Heikkinen; Saeed Alassiri; Dirk-Rolf Gieselmann; Roland Frankenberger; Timo Sorsa
Journal:  Clin Exp Dent Res       Date:  2022-02-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.